HEADER TRANSFERASE 24-NOV-10 3PPL TITLE CRYSTAL STRUCTURE OF AN ASPARTATE TRANSAMINASE (NCGL0237, CGL0240) TITLE 2 FROM CORYNEBACTERIUM GLUTAMICUM ATCC 13032 KITASATO AT 1.25 A TITLE 3 RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: ASPARTATE AMINOTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 2.6.1.1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CORYNEBACTERIUM GLUTAMICUM; SOURCE 3 ORGANISM_COMMON: BREVIBACTERIUM FLAVUM; SOURCE 4 ORGANISM_TAXID: 196627; SOURCE 5 STRAIN: ATCC 13032 KITASATO; SOURCE 6 GENE: ASPB, CG0294; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS AMINOTRANSFERASE, DIMER, PLP-DEPENDENT TRANSFERASE-LIKE FOLD, KEYWDS 2 STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, KEYWDS 3 PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 3 25-OCT-17 3PPL 1 REMARK REVDAT 2 20-JUL-11 3PPL 1 KEYWDS REVDAT 1 22-DEC-10 3PPL 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF AN ASPARTATE TRANSAMINASE (NCGL0237, JRNL TITL 2 CGL0240) FROM CORYNEBACTERIUM GLUTAMICUM ATCC 13032 KITASATO JRNL TITL 3 AT 1.25 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0110 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.32 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 3 NUMBER OF REFLECTIONS : 241986 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.106 REMARK 3 R VALUE (WORKING SET) : 0.105 REMARK 3 FREE R VALUE : 0.124 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 12140 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.25 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.28 REMARK 3 REFLECTION IN BIN (WORKING SET) : 15868 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.94 REMARK 3 BIN R VALUE (WORKING SET) : 0.1590 REMARK 3 BIN FREE R VALUE SET COUNT : 838 REMARK 3 BIN FREE R VALUE : 0.1840 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6483 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 1228 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 10.29 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 14.53 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.17000 REMARK 3 B22 (A**2) : 0.20000 REMARK 3 B33 (A**2) : -0.31000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.16000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.031 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.017 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 0.860 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.985 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.981 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 7404 ; 0.014 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 4975 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 10198 ; 1.598 ; 1.961 REMARK 3 BOND ANGLES OTHERS (DEGREES): 12206 ; 0.966 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1018 ; 5.991 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 341 ;34.581 ;24.370 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1208 ;11.128 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 48 ;12.842 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1103 ; 0.101 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 8713 ; 0.010 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1545 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 4632 ; 1.478 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1861 ; 0.715 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 7557 ; 2.178 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2772 ; 3.231 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2600 ; 4.789 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 12379 ; 1.382 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 1303 ; 8.924 ; 3.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 12135 ; 4.085 ; 3.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. 2. A MET-INHIBITION PROTOCOL WAS USED FOR REMARK 3 SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE REMARK 3 OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. 3. A PYRIDOXAL-5'-PHOSPHATE (PLP) MOLECULE IS REMARK 3 MODELED IN THE ACTIVE SITE OF EACH MONOMER. 4. AN UNKNOWN LIGAND REMARK 3 (UNL) HAS BEEN MODELED NEAR PLP. 5. THE OCCUPANCIES OF ATOMS IN REMARK 3 ALTERNATE CONFORMATIONS WERE REFINED BY PHENIX SOFTWARE. 3. REMARK 3 GLYCEROL (GOL) MOLECULES FROM THE CRYOPROTECTION SOLUTION ARE REMARK 3 MODELED. REMARK 4 REMARK 4 3PPL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-DEC-10. REMARK 100 THE DEPOSITION ID IS D_1000062663. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-FEB-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91837,0.97944,0.97908 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(111) BENT REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 241991 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.250 REMARK 200 RESOLUTION RANGE LOW (A) : 29.324 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.1 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.03500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.0400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.29 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.27600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.750 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M SODIUM CHLORIDE, 20.0% REMARK 280 POLYETHYLENE GLYCOL 8000, 0.1M PHOSPHATE-CITRATE PH 4.2, REMARK 280 ADDITIVE: 0.001 M ALPHA-KETOGLUTARIC ACID, NANODROP', VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 48.87750 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.21200 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 48.87750 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 27.21200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: ANALYTICAL SIZE EXCLUSION CHROMATOGRAPHY WITH STATIC LIGHT REMARK 300 SCATTERING SUPPORTS THE ASSIGNMENT OF A DIMER AS A SIGNIFICANT REMARK 300 OLIGOMERIZATION STATE IN SOLUTION. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7540 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29330 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MSE A 1 REMARK 465 ASN A 426 REMARK 465 GLY B 0 REMARK 465 MSE B 1 REMARK 465 SER B 2 REMARK 465 SER B 3 REMARK 465 ASN B 426 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 34 CD CE NZ REMARK 470 LYS A 59 CE NZ REMARK 470 GLU A 131 CD OE1 OE2 REMARK 470 GLU A 199 CD OE1 OE2 REMARK 470 GLU A 231 CD OE1 OE2 REMARK 470 GLU A 234 CG CD OE1 OE2 REMARK 470 LYS A 278 CE NZ REMARK 470 LYS B 34 CD CE NZ REMARK 470 LYS B 129 CE NZ REMARK 470 GLU B 131 CD OE1 OE2 REMARK 470 GLU B 209 CD OE1 OE2 REMARK 470 GLU B 234 CG CD OE1 OE2 REMARK 470 LYS B 278 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 SER B 256 CB SER B 256 OG -0.100 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 13 NE - CZ - NH2 ANGL. DEV. = 3.8 DEGREES REMARK 500 ASP A 48 CB - CG - OD1 ANGL. DEV. = 10.3 DEGREES REMARK 500 ASP A 48 CB - CG - OD2 ANGL. DEV. = -11.1 DEGREES REMARK 500 ASP B 10 CB - CG - OD1 ANGL. DEV. = 5.6 DEGREES REMARK 500 ARG B 23 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 62 17.79 -142.88 REMARK 500 ASP A 101 -151.26 -89.56 REMARK 500 HIS A 226 59.50 -100.64 REMARK 500 THR A 261 -86.61 -108.09 REMARK 500 THR A 261 -91.38 -108.09 REMARK 500 PHE B 62 18.84 -140.11 REMARK 500 ASP B 101 -149.92 -88.87 REMARK 500 HIS B 226 58.97 -99.68 REMARK 500 THR B 261 -82.15 -114.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PLP A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PLP B 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 700 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 701 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 390716 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THIS CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING REMARK 999 ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 3PPL A 1 426 UNP Q6M8B5 Q6M8B5_CORGL 1 426 DBREF 3PPL B 1 426 UNP Q6M8B5 Q6M8B5_CORGL 1 426 SEQADV 3PPL GLY A 0 UNP Q6M8B5 LEADER SEQUENCE SEQADV 3PPL GLY B 0 UNP Q6M8B5 LEADER SEQUENCE SEQRES 1 A 427 GLY MSE SER SER VAL SER LEU GLN ASP PHE ASP ALA GLU SEQRES 2 A 427 ARG ILE GLY LEU PHE HIS GLU ASP ILE LYS ARG LYS PHE SEQRES 3 A 427 ASP GLU LEU LYS SER LYS ASN LEU LYS LEU ASP LEU THR SEQRES 4 A 427 ARG GLY LYS PRO SER SER GLU GLN LEU ASP PHE ALA ASP SEQRES 5 A 427 GLU LEU LEU ALA LEU PRO GLY LYS GLY ASP PHE LYS ALA SEQRES 6 A 427 ALA ASP GLY THR ASP VAL ARG ASN TYR GLY GLY LEU ASP SEQRES 7 A 427 GLY ILE VAL ASP ILE ARG GLN ILE TRP ALA ASP LEU LEU SEQRES 8 A 427 GLY VAL PRO VAL GLU GLN VAL LEU ALA GLY ASP ALA SER SEQRES 9 A 427 SER LEU ASN ILE MSE PHE ASP VAL ILE SER TRP SER TYR SEQRES 10 A 427 ILE PHE GLY ASN ASN ASP SER VAL GLN PRO TRP SER LYS SEQRES 11 A 427 GLU GLU THR VAL LYS TRP ILE CYS PRO VAL PRO GLY TYR SEQRES 12 A 427 ASP ARG HIS PHE SER ILE THR GLU ARG PHE GLY PHE GLU SEQRES 13 A 427 MSE ILE SER VAL PRO MSE ASN GLU ASP GLY PRO ASP MSE SEQRES 14 A 427 ASP ALA VAL GLU GLU LEU VAL LYS ASN PRO GLN VAL LYS SEQRES 15 A 427 GLY MSE TRP VAL VAL PRO VAL PHE SER ASN PRO THR GLY SEQRES 16 A 427 PHE THR VAL THR GLU ASP VAL ALA LYS ARG LEU SER ALA SEQRES 17 A 427 MSE GLU THR ALA ALA PRO ASP PHE ARG VAL VAL TRP ASP SEQRES 18 A 427 ASN ALA TYR ALA VAL HIS THR LEU THR ASP GLU PHE PRO SEQRES 19 A 427 GLU VAL ILE ASP ILE VAL GLY LEU GLY GLU ALA ALA GLY SEQRES 20 A 427 ASN PRO ASN ARG PHE TRP ALA PHE THR SER THR SER LYS SEQRES 21 A 427 ILE THR LEU ALA GLY ALA GLY VAL SER PHE PHE LEU THR SEQRES 22 A 427 SER ALA GLU ASN ARG LYS TRP TYR THR GLY HIS ALA GLY SEQRES 23 A 427 ILE ARG GLY ILE GLY PRO ASN LYS VAL ASN GLN LEU ALA SEQRES 24 A 427 HIS ALA ARG TYR PHE GLY ASP ALA GLU GLY VAL ARG ALA SEQRES 25 A 427 VAL MSE ARG LYS HIS ALA ALA SER LEU ALA PRO LYS PHE SEQRES 26 A 427 ASN LYS VAL LEU GLU ILE LEU ASP SER ARG LEU ALA GLU SEQRES 27 A 427 TYR GLY VAL ALA GLN TRP THR VAL PRO ALA GLY GLY TYR SEQRES 28 A 427 PHE ILE SER LEU ASP VAL VAL PRO GLY THR ALA SER ARG SEQRES 29 A 427 VAL ALA GLU LEU ALA LYS GLU ALA GLY ILE ALA LEU THR SEQRES 30 A 427 GLY ALA GLY SER SER TYR PRO LEU ARG GLN ASP PRO GLU SEQRES 31 A 427 ASN LYS ASN LEU ARG LEU ALA PRO SER LEU PRO PRO VAL SEQRES 32 A 427 GLU GLU LEU GLU VAL ALA MSE ASP GLY VAL ALA THR CYS SEQRES 33 A 427 VAL LEU LEU ALA ALA ALA GLU HIS TYR ALA ASN SEQRES 1 B 427 GLY MSE SER SER VAL SER LEU GLN ASP PHE ASP ALA GLU SEQRES 2 B 427 ARG ILE GLY LEU PHE HIS GLU ASP ILE LYS ARG LYS PHE SEQRES 3 B 427 ASP GLU LEU LYS SER LYS ASN LEU LYS LEU ASP LEU THR SEQRES 4 B 427 ARG GLY LYS PRO SER SER GLU GLN LEU ASP PHE ALA ASP SEQRES 5 B 427 GLU LEU LEU ALA LEU PRO GLY LYS GLY ASP PHE LYS ALA SEQRES 6 B 427 ALA ASP GLY THR ASP VAL ARG ASN TYR GLY GLY LEU ASP SEQRES 7 B 427 GLY ILE VAL ASP ILE ARG GLN ILE TRP ALA ASP LEU LEU SEQRES 8 B 427 GLY VAL PRO VAL GLU GLN VAL LEU ALA GLY ASP ALA SER SEQRES 9 B 427 SER LEU ASN ILE MSE PHE ASP VAL ILE SER TRP SER TYR SEQRES 10 B 427 ILE PHE GLY ASN ASN ASP SER VAL GLN PRO TRP SER LYS SEQRES 11 B 427 GLU GLU THR VAL LYS TRP ILE CYS PRO VAL PRO GLY TYR SEQRES 12 B 427 ASP ARG HIS PHE SER ILE THR GLU ARG PHE GLY PHE GLU SEQRES 13 B 427 MSE ILE SER VAL PRO MSE ASN GLU ASP GLY PRO ASP MSE SEQRES 14 B 427 ASP ALA VAL GLU GLU LEU VAL LYS ASN PRO GLN VAL LYS SEQRES 15 B 427 GLY MSE TRP VAL VAL PRO VAL PHE SER ASN PRO THR GLY SEQRES 16 B 427 PHE THR VAL THR GLU ASP VAL ALA LYS ARG LEU SER ALA SEQRES 17 B 427 MSE GLU THR ALA ALA PRO ASP PHE ARG VAL VAL TRP ASP SEQRES 18 B 427 ASN ALA TYR ALA VAL HIS THR LEU THR ASP GLU PHE PRO SEQRES 19 B 427 GLU VAL ILE ASP ILE VAL GLY LEU GLY GLU ALA ALA GLY SEQRES 20 B 427 ASN PRO ASN ARG PHE TRP ALA PHE THR SER THR SER LYS SEQRES 21 B 427 ILE THR LEU ALA GLY ALA GLY VAL SER PHE PHE LEU THR SEQRES 22 B 427 SER ALA GLU ASN ARG LYS TRP TYR THR GLY HIS ALA GLY SEQRES 23 B 427 ILE ARG GLY ILE GLY PRO ASN LYS VAL ASN GLN LEU ALA SEQRES 24 B 427 HIS ALA ARG TYR PHE GLY ASP ALA GLU GLY VAL ARG ALA SEQRES 25 B 427 VAL MSE ARG LYS HIS ALA ALA SER LEU ALA PRO LYS PHE SEQRES 26 B 427 ASN LYS VAL LEU GLU ILE LEU ASP SER ARG LEU ALA GLU SEQRES 27 B 427 TYR GLY VAL ALA GLN TRP THR VAL PRO ALA GLY GLY TYR SEQRES 28 B 427 PHE ILE SER LEU ASP VAL VAL PRO GLY THR ALA SER ARG SEQRES 29 B 427 VAL ALA GLU LEU ALA LYS GLU ALA GLY ILE ALA LEU THR SEQRES 30 B 427 GLY ALA GLY SER SER TYR PRO LEU ARG GLN ASP PRO GLU SEQRES 31 B 427 ASN LYS ASN LEU ARG LEU ALA PRO SER LEU PRO PRO VAL SEQRES 32 B 427 GLU GLU LEU GLU VAL ALA MSE ASP GLY VAL ALA THR CYS SEQRES 33 B 427 VAL LEU LEU ALA ALA ALA GLU HIS TYR ALA ASN MODRES 3PPL MSE A 108 MET SELENOMETHIONINE MODRES 3PPL MSE A 156 MET SELENOMETHIONINE MODRES 3PPL MSE A 161 MET SELENOMETHIONINE MODRES 3PPL MSE A 168 MET SELENOMETHIONINE MODRES 3PPL MSE A 183 MET SELENOMETHIONINE MODRES 3PPL MSE A 208 MET SELENOMETHIONINE MODRES 3PPL MSE A 313 MET SELENOMETHIONINE MODRES 3PPL MSE A 409 MET SELENOMETHIONINE MODRES 3PPL MSE B 108 MET SELENOMETHIONINE MODRES 3PPL MSE B 156 MET SELENOMETHIONINE MODRES 3PPL MSE B 161 MET SELENOMETHIONINE MODRES 3PPL MSE B 168 MET SELENOMETHIONINE MODRES 3PPL MSE B 183 MET SELENOMETHIONINE MODRES 3PPL MSE B 208 MET SELENOMETHIONINE MODRES 3PPL MSE B 313 MET SELENOMETHIONINE MODRES 3PPL MSE B 409 MET SELENOMETHIONINE HET MSE A 108 8 HET MSE A 156 8 HET MSE A 161 8 HET MSE A 168 8 HET MSE A 183 16 HET MSE A 208 8 HET MSE A 313 8 HET MSE A 409 13 HET MSE B 108 8 HET MSE B 156 8 HET MSE B 161 8 HET MSE B 168 8 HET MSE B 183 16 HET MSE B 208 8 HET MSE B 313 8 HET MSE B 409 13 HET PLP A 500 16 HET UNL A 600 12 HET PLP B 500 16 HET UNL B 600 10 HET GOL B 700 6 HET GOL B 701 6 HETNAM MSE SELENOMETHIONINE HETNAM PLP PYRIDOXAL-5'-PHOSPHATE HETNAM UNL UNKNOWN LIGAND HETNAM GOL GLYCEROL HETSYN PLP VITAMIN B6 PHOSPHATE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 MSE 16(C5 H11 N O2 SE) FORMUL 3 PLP 2(C8 H10 N O6 P) FORMUL 7 GOL 2(C3 H8 O3) FORMUL 9 HOH *1228(H2 O) HELIX 1 1 SER A 5 PHE A 9 5 5 HELIX 2 2 ASP A 10 LYS A 31 1 22 HELIX 3 3 SER A 43 PHE A 49 1 7 HELIX 4 4 ALA A 50 LEU A 56 5 7 HELIX 5 5 ILE A 79 GLY A 91 1 13 HELIX 6 6 PRO A 93 GLU A 95 5 3 HELIX 7 7 SER A 103 GLY A 119 1 17 HELIX 8 8 PRO A 126 GLU A 130 5 5 HELIX 9 9 TYR A 142 PHE A 152 1 11 HELIX 10 10 ASP A 167 VAL A 175 1 9 HELIX 11 11 THR A 198 MSE A 208 1 11 HELIX 12 12 ASP A 237 ALA A 245 1 9 HELIX 13 13 SER A 273 GLY A 288 1 16 HELIX 14 14 ASN A 292 GLY A 304 1 13 HELIX 15 15 ASP A 305 ALA A 336 1 32 HELIX 16 16 GLU A 337 GLY A 339 5 3 HELIX 17 17 THR A 360 ALA A 371 1 12 HELIX 18 18 TYR A 382 GLN A 386 5 5 HELIX 19 19 PRO A 401 ALA A 425 1 25 HELIX 20 20 SER B 5 PHE B 9 5 5 HELIX 21 21 ASP B 10 LYS B 31 1 22 HELIX 22 22 SER B 43 PHE B 49 1 7 HELIX 23 23 ALA B 50 LEU B 56 5 7 HELIX 24 24 ILE B 79 GLY B 91 1 13 HELIX 25 25 PRO B 93 GLU B 95 5 3 HELIX 26 26 SER B 103 GLY B 119 1 17 HELIX 27 27 PRO B 126 GLU B 130 5 5 HELIX 28 28 TYR B 142 PHE B 152 1 11 HELIX 29 29 ASP B 167 VAL B 175 1 9 HELIX 30 30 THR B 198 MSE B 208 1 11 HELIX 31 31 ASP B 237 ALA B 245 1 9 HELIX 32 32 SER B 273 GLY B 288 1 16 HELIX 33 33 ASN B 292 GLY B 304 1 13 HELIX 34 34 ASP B 305 ALA B 336 1 32 HELIX 35 35 GLU B 337 GLY B 339 5 3 HELIX 36 36 THR B 360 ALA B 371 1 12 HELIX 37 37 TYR B 382 GLN B 386 5 5 HELIX 38 38 PRO B 401 ALA B 425 1 25 SHEET 1 A 2 LEU A 35 ASP A 36 0 SHEET 2 A 2 ILE A 373 ALA A 374 1 O ALA A 374 N LEU A 35 SHEET 1 B 8 VAL A 97 ALA A 99 0 SHEET 2 B 8 SER A 268 LEU A 271 -1 O PHE A 270 N LEU A 98 SHEET 3 B 8 PHE A 251 SER A 256 -1 N ALA A 253 O LEU A 271 SHEET 4 B 8 ARG A 216 ASP A 220 1 N VAL A 217 O TRP A 252 SHEET 5 B 8 VAL A 180 VAL A 185 1 N VAL A 185 O ASP A 220 SHEET 6 B 8 LYS A 134 VAL A 139 1 N ILE A 136 O GLY A 182 SHEET 7 B 8 GLU A 155 ASN A 162 1 O ILE A 157 N CYS A 137 SHEET 8 B 8 GLY A 165 PRO A 166 -1 O GLY A 165 N ASN A 162 SHEET 1 C 3 GLN A 342 TRP A 343 0 SHEET 2 C 3 ILE A 352 ASP A 355 -1 O ASP A 355 N GLN A 342 SHEET 3 C 3 ASN A 392 LEU A 395 -1 O LEU A 393 N LEU A 354 SHEET 1 D 2 LEU B 35 ASP B 36 0 SHEET 2 D 2 ILE B 373 ALA B 374 1 O ALA B 374 N LEU B 35 SHEET 1 E 8 VAL B 97 ALA B 99 0 SHEET 2 E 8 SER B 268 LEU B 271 -1 O PHE B 270 N LEU B 98 SHEET 3 E 8 PHE B 251 SER B 256 -1 N ALA B 253 O LEU B 271 SHEET 4 E 8 ARG B 216 ASP B 220 1 N VAL B 217 O TRP B 252 SHEET 5 E 8 VAL B 180 VAL B 185 1 N VAL B 185 O ASP B 220 SHEET 6 E 8 LYS B 134 VAL B 139 1 N ILE B 136 O GLY B 182 SHEET 7 E 8 GLU B 155 ASN B 162 1 O ILE B 157 N CYS B 137 SHEET 8 E 8 GLY B 165 PRO B 166 -1 O GLY B 165 N ASN B 162 SHEET 1 F 3 GLN B 342 TRP B 343 0 SHEET 2 F 3 ILE B 352 ASP B 355 -1 O ASP B 355 N GLN B 342 SHEET 3 F 3 ASN B 392 LEU B 395 -1 O LEU B 393 N LEU B 354 LINK C ILE A 107 N MSE A 108 1555 1555 1.34 LINK C MSE A 108 N PHE A 109 1555 1555 1.33 LINK C AGLU A 155 N MSE A 156 1555 1555 1.33 LINK C BGLU A 155 N MSE A 156 1555 1555 1.33 LINK C MSE A 156 N ILE A 157 1555 1555 1.31 LINK C PRO A 160 N MSE A 161 1555 1555 1.34 LINK C MSE A 161 N ASN A 162 1555 1555 1.33 LINK C AASP A 167 N MSE A 168 1555 1555 1.33 LINK C BASP A 167 N MSE A 168 1555 1555 1.33 LINK C MSE A 168 N ASP A 169 1555 1555 1.33 LINK C GLY A 182 N AMSE A 183 1555 1555 1.32 LINK C GLY A 182 N BMSE A 183 1555 1555 1.34 LINK C AMSE A 183 N TRP A 184 1555 1555 1.33 LINK C BMSE A 183 N TRP A 184 1555 1555 1.34 LINK C ALA A 207 N MSE A 208 1555 1555 1.33 LINK C MSE A 208 N AGLU A 209 1555 1555 1.32 LINK C MSE A 208 N BGLU A 209 1555 1555 1.34 LINK C VAL A 312 N MSE A 313 1555 1555 1.33 LINK C MSE A 313 N ARG A 314 1555 1555 1.34 LINK C ALA A 408 N MSE A 409 1555 1555 1.33 LINK C MSE A 409 N ASP A 410 1555 1555 1.32 LINK C ILE B 107 N MSE B 108 1555 1555 1.33 LINK C MSE B 108 N PHE B 109 1555 1555 1.33 LINK C AGLU B 155 N MSE B 156 1555 1555 1.32 LINK C BGLU B 155 N MSE B 156 1555 1555 1.33 LINK C MSE B 156 N ILE B 157 1555 1555 1.32 LINK C PRO B 160 N MSE B 161 1555 1555 1.33 LINK C MSE B 161 N ASN B 162 1555 1555 1.34 LINK C ASP B 167 N MSE B 168 1555 1555 1.33 LINK C MSE B 168 N ASP B 169 1555 1555 1.32 LINK C GLY B 182 N AMSE B 183 1555 1555 1.32 LINK C GLY B 182 N BMSE B 183 1555 1555 1.33 LINK C AMSE B 183 N TRP B 184 1555 1555 1.32 LINK C BMSE B 183 N TRP B 184 1555 1555 1.33 LINK C ALA B 207 N MSE B 208 1555 1555 1.34 LINK C MSE B 208 N GLU B 209 1555 1555 1.32 LINK C VAL B 312 N MSE B 313 1555 1555 1.33 LINK C MSE B 313 N AARG B 314 1555 1555 1.33 LINK C MSE B 313 N BARG B 314 1555 1555 1.32 LINK C ALA B 408 N MSE B 409 1555 1555 1.33 LINK C MSE B 409 N ASP B 410 1555 1555 1.32 CISPEP 1 LEU A 56 PRO A 57 0 5.67 CISPEP 2 VAL A 139 PRO A 140 0 -10.89 CISPEP 3 ASN A 191 PRO A 192 0 8.91 CISPEP 4 LEU B 56 PRO B 57 0 4.93 CISPEP 5 VAL B 139 PRO B 140 0 -6.92 CISPEP 6 ASN B 191 PRO B 192 0 12.27 SITE 1 AC1 16 SER A 103 SER A 104 LEU A 105 TYR A 142 SITE 2 AC1 16 VAL A 186 ASN A 191 ASP A 220 ALA A 222 SITE 3 AC1 16 TYR A 223 SER A 256 SER A 258 LYS A 259 SITE 4 AC1 16 HOH A 723 HOH A 735 HOH A 891 TYR B 73 SITE 1 AC2 16 TYR A 73 SER B 103 SER B 104 LEU B 105 SITE 2 AC2 16 TYR B 142 VAL B 186 ASN B 191 ASP B 220 SITE 3 AC2 16 ALA B 222 TYR B 223 SER B 256 SER B 258 SITE 4 AC2 16 LYS B 259 HOH B 715 HOH B 745 HOH B 892 SITE 1 AC3 9 ASP B 20 ALA B 321 PHE B 324 LEU B 328 SITE 2 AC3 9 VAL B 345 PRO B 346 HOH B 776 HOH B1032 SITE 3 AC3 9 HOH B1862 SITE 1 AC4 4 GLN B 342 TRP B 343 HOH B1316 HOH B1336 CRYST1 97.755 54.424 176.340 90.00 101.60 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010230 0.000000 0.002100 0.00000 SCALE2 0.000000 0.018374 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005789 0.00000 MASTER 379 0 22 38 26 0 12 6 0 0 0 66 END